News

Learn how and why East Indian Sandalwood Oil (EISO) is making international headlines as a unique, non-substitutable botanical drug candidate.

News

ViroXis Inc., A San Antonio Start-up Company, Apparently is Barking Up the Right Tree:

Posted on

It has has a lead drug candidate that already completed Phase II testing based on the East Indian sandalwood tree. Founded in 2006, the company is developing botanically derived pharmaceuticals, most of them in a class known as terpenoids. Its lead drug candidate, the albuterpenoids, is being developed as a topical agent for problematic human papilloma virus (HPV) infections of the […]Read More ViroXis Inc., A San Antonio Start-up Company, Apparently is Barking Up the Right Tree:

ViroXis Wins Statewide Recognition at Life Science Conference

Posted on

Biomedical start-up company ViroXis Corp. won the 2009 Michael E. DeBakey Memorial Life Science Award at the recent Texas Life Science Conference in Houston. ViroXis is a San Antonio-based company that is developing a novel, patented antiviral compound for the treatment of warts. The Michael E. DeBakey Memorial award is presented to the “undiscovered” life science company with the highest […]Read More ViroXis Wins Statewide Recognition at Life Science Conference

Viroxis Secures Sandalwood Supply Agreement with TFS Corporation

Posted on

SAN ANTONIO, Texas and Perth, Western Australia, 28th October 2009: ViroXis Corporation today announced a multi-million dollar agreement with TFS Corporation (ASX: TFC) to supply up to three tonnes of East India Sandalwood Oil per annum for the development of its botanical drug, albuterpenoids. The long-term supply agreement is conditional upon ViroXis gaining regulatory approval for commercialisation of albuterpenoids. The […]Read More Viroxis Secures Sandalwood Supply Agreement with TFS Corporation